# Noctrix Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/noctrix-health

- Industry: Medical Devices & Equipment
- Headquarters: Pleasanton, US
- Website: www.noctrixhealth.com
- Total disclosed funding: $57M
- Latest round: Series C (Jan 16, 2024)
- Investors on record: 7

## About

Founded in 2018 by Jonathan Charlesworth and Shriram Raghunathan, and based in California, US, Noctrix Health, Inc. operates as the developer and manufacturer of a wearable therapeutic device used for the management and treatment of Restless Legs Syndrome (RLS). In August 2025, Noctrix Health, Inc. raised an undisclosed amount of equity funding from new investors Blue Venture Fund and Sandbox Industries. The round was part of a larger USD 33.5 million debt and equity funding.

Noctrix Health offers wearable therapeutic devices designed as alternatives to pharmaceuticals for managing chronic neurological conditions, like the Restless Legs Syndrome (RLS). The company's technology, known as Tonic Motor Activation (TOMAC), has received FDA marketing authorization and Breakthrough Device Designation. 

The company plans to use August 2025 funding to accelerate its market operation and widen its team.

## Funding rounds

- Series C, Jan 16, 2024, $40M — OrbiMed Advisors, ResMed Inc., Asahi Kasei Corporation, Sectoral Asset Management, Treo Ventures, Angelini Ventures
- Series B, Jan 4, 2021, $17M — OrbiMed Advisors, LivaNova PLC, Treo Ventures

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B, Series C
- LivaNova PLC — Series B
- Treo Ventures (https://capitalatlas.ai/funds/treo-ventures) — Series B, Series C
- ResMed Inc. — Series C
- Asahi Kasei Corporation — Series C
- Sectoral Asset Management (https://capitalatlas.ai/funds/sectoral-asset-management) — Series C
- Angelini Ventures (https://capitalatlas.ai/funds/angelini-ventures) — Series C